Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-029458
Filing Date
2024-03-11
Accepted
2024-03-11 17:36:29
Documents
1
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5063
  Complete submission text file 0000950170-24-029458.txt   6552
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 TIMES SQAURE, 12TH FLOOR NEW YORK NY 10036
Business Address
SBLENDORIO GLENN (Reporting) CIK: 0001277478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 24739356